| Nov 21 |
Earnings Scheduled For November 21, 2024
|
| Nov 20 |
Evogene Q3 2024 Earnings Preview
|
| Nov 19 |
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
|
| Nov 7 |
Evogene Schedules Third Quarter 2024 Financial Results Release
|
| Oct 31 |
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
|
| Oct 29 |
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
|
| Oct 8 |
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
|
| Sep 30 |
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
|
| Aug 23 |
Evogene prices $5.5M direct offering
|
| Aug 23 |
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
|
